Diasorin SpA (STU:34D) Inventories, Work In Process: €79 Mil (As of Dec. 2025)


STU:34D Diasorin SpA STU:34D
76 GF Score
Price €68.18
GF Value €89.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA Inventories, Work In Process?

Diasorin SpA STU:34D +2.87% 76 Inventories, Work In Process is €79 Mil as of Dec. 2025. GuruFocus rates STU:34D with a GF Score™ of 76/100 and a GF Value™ of €89.87 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Diasorin SpA's work in process for the quarter that ended in Dec. 2025 was €79 Mil.

Diasorin SpA Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Diasorin SpA's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA Inventories, Work In Process Chart

Diasorin SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.61 74.84 76.39 82.34 78.65

Diasorin SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 78.55 0.00 78.65 0.00
STU:34D
76GF Score
Diasorin SpA STU:34D
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diasorin SpA Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €79 Mil mean?
Diasorin SpA (STU:34D) has a Inventories, Work In Process of €79 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Diasorin SpA and its competitors.
Is Diasorin SpA's Inventories, Work In Process too high?
Diasorin SpA's current Inventories, Work In Process is €79 Mil. Overall, Diasorin SpA has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's Inventories, Work In Process compare to TMO and DHR?
Diasorin SpA's Inventories, Work In Process of €79 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Diagnostics & Research company?
A good Inventories, Work In Process depends on the Medical Diagnostics & Research industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Diasorin SpA and its competitors. Diasorin SpA's current Inventories, Work In Process is €79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (STU:34D) is currently considered Modestly Undervalued. The stock's GF Value™ is €89.87, compared to a current price of €68.18 — trading 24.1% below its estimated fair value. The current Inventories, Work In Process is €79 Mil. Diasorin SpA's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Diasorin SpA (STU:34D), the current Inventories, Work In Process is €79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diasorin SpA (STU:34D) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €68.18 is trading 24.1% below its estimated GF Value™ of €89.87. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for STU:34D:

  • Inventories, Work In Process: €79 Mil
  • GF Value™: €89.87 vs. price of €68.18 (24.1% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the STU:34D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
76GF Score

Get the complete analysis for STU:34D

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.18
Price
€89.87
GF Value